Journal of the American Society of Nephrology
2007 JASN IMPACT FACTOR 7.111 HOME   AUTHOR INFO   EDITORIAL BOARD   SUBSCRIBE   FEEDBACK   ALERTS   HELP 
    advanced
CURRENT ISSUE ARCHIVES JASN Express ONLINE SUBMISSION


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Takayama, T.
Right arrow Articles by Ogawa, Y.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Takayama, T.
Right arrow Articles by Ogawa, Y.
J Am Soc Nephrol 14:939-946, 2003
© 2003 American Society of Nephrology

Control of Oxalate Formation from L-Hydroxyproline in Liver Mitochondria

Tatsuya Takayama*, Kimio Fujita*, Kazuo Suzuki*, Michiko Sakaguchi*, Michio Fujie{dagger}, Erina Nagai{ddagger}, Shinya Watanabe{ddagger}, Arata Ichiyama{ddagger} and Yoshihide Ogawa§

*Department of Urology, {dagger}Research Equipment Center, and {ddagger}Department of Biochemistry I, Hamamatsu University School of Medicine, Hamamatsu, Japan; and §Department of Urology, University of the Ryukyus, Okinawa, Japan.

Correspondence to Dr. Tatsuya Takayama, Department of Urology, Hamamatsu University School of Medicine, 1-20-1 Handayama, Hamamatsu, Shizuoka 431-3192, Japan. Phone: 81-53-435-2306; Fax: 81-53-435-2305;


    Abstract
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
ABSTRACT. Serine:pyruvate/alanine:glyoxylate aminotransferase (SPT/AGT) is largely located in mitochondria in carnivores, whereas it is entirely found within peroxisomes in herbivores and humans. In rat liver, SPT/AGT is found in both of these organelles, and only the mitochondrial enzyme is markedly induced by glucagon. Although SPT/AGT is a bifunctional enzyme involved in the metabolism of both L-serine and glyoxylate, its contribution to L-serine metabolism is independent of mitochondrial or peroxisomal localization (Xue HH et al., J Biol Chem 274: 16028-16033, 1999). Therefore, the species-specific and food habit-dependent organelle distribution might be required for proper metabolism of glyoxylate at the subcellular site of its formation. Glyoxylate formation from glycolate and that from L-hydroxyproline have been shown to occur in peroxisomes and mitochondria, respectively. The present study found that urinary excretion of oxalate was markedly increased when a large dose of L-hydroxyproline or glycolate was administered to rats. Oxalate formation from L-hydroxyproline but not that from glycolate was significantly reduced when mitochondrial SPT/AGT had been induced by glucagon. The hydroxyproline content of collagen is 10 to 13%, and collagen accounts for about 30% of total animal protein; therefore, these results suggest that an important role of mitochondrial SPT/AGT in carnivores is to convert L-hydroxyproline-derived glyoxylate into glycine in situ, preventing undesirable overflow into the production of oxalate. E-mail: takayama@hama-med.ac.jp


    Introduction
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
In herbivores and humans, a major source of glyoxylate, an immediate precursor of oxalate, is believed to be oxidation of glycolate by glycolate oxidase in liver peroxisomes. Glycolate is an intermediate of photorespiration and is thus much higher in content in plants than in animal tissues (1). Glyoxylate is also formed in liver and kidney mitochondria from 4-hydroxy-2-ketoglutarate (HKG), an intermediate of L-hydroxyproline metabolism (2,3 ). Mitochondrial production of glyoxylate from hydroxyproline is assumed to be significant in carnivores, because the hydroxyproline content of collagen is about 10 to 13% (4) and collagen accounts for about 30% of total animal protein. The major metabolic pathway of hydroxyproline-derived glyoxylate in rat kidney has been suggested to be transamination to glycine (3). Glycine thus formed may be oxidized to CO2 and ammonia by the mitochondrial glycine cleavage enzyme system, and in conjugation with this oxidation another molecule of glycine is converted to L-serine by mitochondrial serine hydroxymethyltransferase (5). A candidate enzyme responsible for the transamination of glyoxylate to glycine is a dual-functional enzyme, serine:pyruvate/alanine:glyoxylate aminotransferase (SPT/AGT, alternatively named alanine:glyoxylate aminotransferase-1, AGT-1 or serine:pyruvate aminotransferase, SPT). This enzyme was found as SPT (6), and it was later shown to be a predominant enzyme of L-serine metabolism in human, rabbit, and dog livers (7), but its alanine:glyoxylate aminotransferase (AGT) activity has also been proven to be indispensable for proper metabolism of glyoxylate (8).

The relationship between glyoxylate metabolism and the species-specific and food habit-dependent subcellular distribution of SPT/AGT is of interest. This enzyme is located in liver peroxisomes in herbivores and humans and largely in mitochondria in carnivores (9–13 ). In the livers of rats and mice, it is located in both peroxisomes and mitochondria, but only the mitochondrial enzyme is markedly induced by glucagon (9,11,14–16 ). It is generally accepted that the peroxisomal presence of SPT/AGT in herbivores is essential for conversion of glyoxylate formed from glycolate in this organelle into glycine in situ, thus preventing undesirable overflow of it into oxalate.

In the present study, we examined whether mitochondrial SPT/AGT plays a role in removing hydroxyproline-derived glyoxylate from oxidation to oxalate using rats with or without glucagon induction of liver mitochondrial SPT/AGT. For this purpose, we investigated (1) the effect of glucagon on enzymes involved in L-hydroxyproline metabolism (experiment 1), and (2) the effect of glucagon induction of mitochondrial SPT/AGT on oxalate formation from L-hydroxyproline and that from glycolate in vivo (experiment 2).


    Materials and Methods
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
Experiment 1
All animal experiments (experiments 1 and 2) were done at 26°C under a light and dark cycle of 12:12. Glucagon was injected intraperitoneally into 24 h-fasted (deprived of food with free access to water) male Wistar rats of about 170 g at a dose of 300 µg/100 g body wt. Where indicated, the same dose of glucagon was given twice after 24 h and 48 h of fasting. The rats were killed after another 24 h of fasting by exsanguination from the carotid arteries after being rendered unconscious by a blow to the neck, in accordance with the Guidlines for Animal Experimentation of Hamamatsu University School of Medicine. Livers were immediately removed and homogenized using a Potter-Elvehjem homogenizer in 4 vol of 0.25 M sucrose (pH 7.2) containing 3 mM imidazole/HCl, 1 mM EDTA, 0.5 mM phenylmethylsulfonyl fluoride, and 10 µg/ml E-64c for assay of the SPT activity of SPT/AGT, and in 4 vol of chilled water for assay of hydroxyproline oxidase and HKG aldolase. The homogenates were then passed through a layer of cheesecloth and subjected to sonication 5 times for 15 s each with a Blonson Sonifier B-12. When {Delta}1-pyrroline-5-carboxylate (P5C) dehydrogenase was to be assayed, acetone dried powder was prepared from a liver specimen of each rat, and the powder was extracted with 10 vol of chilled water as described by Strecker (17). The reaction mixture (1.0 ml) for the assay of P5C dehydrogenase comprised 50 mM Tris-HCl, 50 µM K-phosphate, 1.2 mM pyrroline 5-carboxylate and acetone powder extract, final pH being close to 8.2. The extract was added last, and the activity was measured at room temperature by the increase in absorbance at 340 nm. The SPT activity of SPT/AGT was determined as described previously (18,19 ). SPT/AGT catalyzes transamination of glyoxylate to glycine with L-alanine or L-serine as an amino acid (rat SPT/AGT shows wider substrate specificity), but the tissue level of this enzyme was represented by the SPT activity in this study, because a single catalytic site is responsible for the three enzymatic activities and determination of SPT activity was free of interference by AGT-2, an isoenzyme of SPT/AGT or AGT-1. Hydroxyproline oxidase and HKG aldolase activities were assayed as described by Carnie et al. (20).

Experiment 2
Male Wistar rats weighing about 170 g were divided into six groups (groups A, B, C, D, E, and F) and fasted for 72 h with free access to water. After 24 h of fasting, rats of groups A, C, and E were given 300 µg/100 g body wt of glucagon intraperitoneally to induce liver mitochondrial SPT/AGT (14,18 ). After 48 h of fasting (24 h after the injection of glucagon), 630 mg (4.8 mmol) of L-hydroxyproline in 2 ml water was administered to rats from groups C and D via a stomach tube. Rats from groups E and F were similarly given 100 mg (1.02 mmol) of Na-glycolate in 1 ml water. Rats from groups A and B did not receive L-hydroxyproline, glycolate, or water, but preliminary experiments showed that oral administration of water caused no significant change in urinary excretion of oxalate and glycolate, especially when their excretion was expressed as the ratios to creatinine. Each animal was then individually housed in a glass metabolic cage, and 24 h-urine was collected (usually from 8:00 to 8:00 of the next day) into glass bottles containing 500 µl of 6 N HCl while the fasting was continued. Then rats were killed and the SPT activity in liver homogenates was determined as described above.

Measurement of Urinary Substances
Oxalate was determined by high performance capillary electrophoresis (HPCE) as described previously (21,22 ), except that urine samples treated with stearate-deactivated charcoal (23) were subjected to HPCE. In another experiment in this study, in which oxalate was determined by both HPCE and an enzymatic method with oxalate oxidase (23), the values measured by the two methods reasonably agreed with each other. Creatinine and glycolate were determined by the Jaffe reaction and HPCE (21,22 ), respectively. Urea and ammonia were determined enzymatically with glutamate dehydrogenase and a combination of urease-S and glutamate dehydrogenase, respectively (24,25 ). Hydroxyproline, proline, glycine, and serine were analyzed by PICO-TAG chromatography.

Materials
Sodium DL-4-hydroxy-2-ketoglutarate (substrate for HKG aldolase) was prepared as described by Carnie et al. (20), except that its barium salt was converted to the sodium salt by exchanging Ba2+ for H+ with a small amount of Dowex 50W-H+ slurry, followed by neutralization of the supernatant to about pH 6 with NaOH. The 2,4-dinitrophenylhydrazone derivative of P5C was prepared, and P5C was generated from the hydrazone as described by Mezl and Knox (26), the concentration of generated P5C being determined with o-aminobenzaldehyde. The 2-aminobenzaldehyde agent and glucagon were obtained from Wako Pure Chemical Industries (Osaka, Japan) and NOVO Nordisk Pharma (Denmark), respectively. Sources of reagents and enzymes used for the assay of the SPT activity of SPT/AGT (18,19 ) have been described in the publications cited.

Statistical Analyses
Values are expressed as mean ± SEM. Intergroup comparisons were made by two-tailed t test for unpaired data, and intragroup comparisons were made by two-way ANOVA, followed by the Newman-Keuls as post hoc test using the SPSS statistical package (SPSS, Inc., Chicago, IL). P < 0.05 was considered statistically significant.


    Results
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
Effect of Glucagon Injection on Enzymes Involved in L-Hydroxyproline Metabolism (Experiment 1)
Induction by glucagon of SPT/AGT in liver mitochondria in the rat (9,11,14–16 ) may be useful as a model for studying the role of this enzyme in the metabolism of glyoxylate formed from L-hydroxyproline in liver mitochondria, provided that other enzymes of hydroxyproline metabolism are not affected by glucagon. In rat liver, SPT/AGT is located in both mitochondria and peroxisomes in a ratio of about 4:6; of these, only mitochondrial SPT/AGT is markedly induced by glucagon (11,14 ). Therefore, the fivefold increase by glucagon of total SPT/AGT activity represented by its SPT activity suggests that mitochondrial SPT/AGT had been induced more than tenfold. We investigated whether hydroxyproline oxidase and HKG aldolase were affected by glucagon under conditions in which mitochondrial SPT/AGT was induced; of the four enzymes involved in the metabolism of L-hydroxyproline (Figure 1), these two enzymes were thought to be specific to hydroxyproline metabolism (27,28 ). P5C dehydrogenase contributes to the metabolism of proline and ornithine in addition to that of hydroxyproline, but its activity was also measured.



View larger version (24K):
[in this window]
[in a new window]
[as a PowerPoint slide]
 
Figure 1. Catabolic pathway of L-hydroxyproline. AspAT, aspartate aminotransferase; DH, dehydrogenase; Hyp, hydroxyproline; OAA, oxaloacetate; 4-OH-Glu, 4-hydroxy-L-glutamate.

 
As shown in Table 1, hydroxyproline oxidase, P5C dehydrogenase, and HKG aldolase did not respond to the injection of glucagon under conditions in which SPT/AGT was substantially induced. Rat liver mitochondrial aspartate aminotransferase was already documented not to respond to 300 µg/100 g body wt of glucagon given intraperitoneally during fasting (29). These results suggest that liver mitochondrial SPT/AGT is induced by glucagon without accompanying changes in the metabolism of L-hydroxyproline to glyoxylate.


View this table:
[in this window]
[in a new window]

 
Table 1. Enzyme activities in the livera
 
Effect of Glucagon Induction of SPT/AGT on Formation of Oxalate from L-Hydroxyproline In Vivo (Experiment 2)
We examined whether glyoxylate formed from L-hydroxyproline in mitochondria was oxidized to oxalate in vivo by orally administering a high dose of L-hydroxyproline to 48 h-fasted control rats. We also investigated whether the formation of L-hydroxyproline-derived oxalate was curtailed when liver mitochondrial SPT/AGT was increased, by comparing urinary oxalate excretion in glucagon-treated rats with that in control rats. In this series of experiments, we took advantage of the slow rate of turnover of SPT/AGT in rat liver mitochondria (18). We repeatedly observed that glucagon induced SPT/AGT in mitochondria almost selectively; once induced, the mitochondrial SPT/AGT maintained the high level of activity for as long as several days (18). In this study, glucagon was injected under fasting conditions, and L-hydroxyproline was given orally 24 h after the glucagon injection, when the induced level of SPT/AGT had reached a plateau as judged from preliminary observation of the time course of the glucagon induction. Urine was then collected for 24 h while fasting was continued and oxalate, glycolate, and other compounds were determined.

Two-way analysis of variation showed that SPT activity was significantly affected by glucagon injection (P = 0.0001) but not by administration of L-hydroxyproline (P = 0.7252). Urinary excretion of oxalate and glycolate was significantly affected by administration of L-hydroxyproline (P = 0.0001 and 0.0012, respectively) and glucagon injection (P = 0.0001 and 0.0019, respectively), and there was a significant interaction between the effect of L-hydroxyproline and glucagon on excretion of oxalate and glycolate (P = 0.0001 and 0.0001, respectively). Urinary excretion of glycine, serine, hydroxyproline, proline, ammonia, and urea was also significantly affected by administration of L-hydroxyproline (P = 0.0025, 0.0004, 0.0001, 0.0001, 0.0001, and 0.0009, respectively) but not by glucagon injection, especially when data were expressed as the ratios to creatinine (P = 0.9949, 0.6885, 0.0882, 0.1752, 0.4995, and 0.3674, respectively).

Administration of L-hydroxyproline caused a large increase in urinary hydroxyproline excretion, as expected (Table 2). Recovery of the administered dose (4.8 mmol) of L-hydroxyproline in urine was 13 to 17%. Because L-hydroxyproline is not utilized as a precursor amino acid for protein synthesis, its only metabolic fate is expected to be catabolism (Figure 1). We therefore presumed that a fairly large amount of L-hydroxyproline had been catabolized in this experiment. Interestingly, a small increase in urinary excretion of proline was also observed (Table 2), suggesting that L-hydroxyproline administration somehow interfered with oxidation of proline.


View this table:
[in this window]
[in a new window]

 
Table 2. Urinary excretion of ammonia, urea, and amino acids after administration of L-hydroxyproline or glycolatea
 
Excretion of glycine, serine, ammonia, and urea was also increased 1.6 to 3.4-fold by administration of L-hydroxyproline (Table 2). Although the amount of glycine and serine excreted into urine was very small, increase in excretion of ammonia plus urea by L-hydroxyproline administration accounted for more than 40% of administered dose of L-hydroxyproline, irrespective of prior induction by glucagon of mitochondrial SPT/AGT. About 15% of administered dose of L-hydroxyproline was excreted into urine unchanged; therefore, the increase in urinary ammonia plus urea represented as much as 50% of the lost (remaining 85%) L-hydroxyproline. These results indicate that a large fraction of administered L-hydroxyproline was metabolized through HKG and glycine in both glucagon-treated and control rats (Figure 2A). It is possible that glyoxylate was metabolized through glycine fairly efficiently, even in the absence of glucagon induction of liver mitochondrial SPT/AGT (Tables 1 to 3).



View larger version (21K):
[in this window]
[in a new window]
[as a PowerPoint slide]
 
Figure 2. Transfer of amino group in the metabolism of L-hydroxyproline (A) and glycolate (B) in rat liver. In the metabolism of L-hydroxyproline (A), amino group derived from this imino acid is removed as L-aspartate in the mitochondrial aspartate aminotransferase-catalyzed reaction. On the other hand, stoichiometric amount of L-alanine is required for conversion of glyoxylate into glycine. The major source of L-alanine in mammalian cells is alanine aminotransferase-catalyzed transfer of amino group from L-glutamate to pyuvate. L-glutamate is in equilibrium with L-aspartate in cells through rapid interconversion catalyzed by aspartate aminotransferase, which is also responsible for transfer of amino group from 4-hydoxy-L-glutamate to oxaloacetate generating HKG and L-aspartate. When a large amount of L-aspartate is supplied from 4-hydroxy-L-glutamate, therefore, a considerable amount of L-glutamate should be generated in association with the formation of HKG. The amino group of L-glutamate is then transferred to glyoxylate via L-alanine to form glycine. Glycine is oxidized to NH3 and CO2 by mitochondrial glycine cleavage enzyme system; in conjugation with this oxidation, another molecule of glycine is converted to L-serine by mitochondrial serine hydroxymethyltrasferase. In rat liver, L-serine is dehydrated by serine dehydratase producing NH3 and pyruvate (37). In the metabolism of glycolate (B), on the other hand, neither L-alanine nor L-glutamate is supplied from glycolate. Therefore, about the same amount of L-glutamate as that used for supply of L-alanine for the metabolism of glyoxylate may be saved from glutamate dehydrogenase-catalyzed oxidation to {alpha}-ketoglutarate and NH3. AlaT, alanine aminotransferase; AspT, aspartate aminotransferase; GCS, glycine cleavage enzyme system; GlDH, glutamate dehydrogenase; {alpha}-KG, {alpha}-ketoglutarate; Me-THF, 5,10-methylenetetrahydrofolate; mAspT, mitochondrial aspartate aminotranferase; OAA, oxaloacetate; OH-L-Glu, 4-hydroxy-L-glutamate; P5C-DH, P5C dehydrogenase; SDH, serine dehydratase; SHMT, serine hydroxymethyltransferase; THF, tetrahydrofolate.

 

View this table:
[in this window]
[in a new window]

 
Table 3. Effect of glucagon induction of mitochondrial SPT/AGT on urinary excretion of oxalate and glycolate after administration of L-hydroxyproline or glycolatea
 
In control rats, urinary excretion of oxalate and glycolate was significantly increased (oxalate, 5.6-fold; glycolate, 2.5-fold) by administration of L-hydroxyproline, although fractional conversion of the "lost" L-hydroxyproline to oxalate plus glycolate was only 0.36%. The increase in oxalate excretion due to L-hydroxyproline administration was distinctly less in glucagon-treated rats than in control rats, and the small amount of L-hydroxyproline-derived glycolate formation was prevented by prior induction of mitochondrial SPT/AGT (Table 3).

Effect of Glucagon Induction of SPT/AGT on Formation of Oxalate from Glycolate (Experiment 2)
Glyoxylate is also produced from glycolate in liver peroxisomes, and according to Harris and Richardson (1) glycolate is much more abundant in plants than in animal tissues; therefore, the peroxisomal presence of SPT/AGT in herbivores may be required to prevent excessive oxalate production by effectively metabolizing glycolate-derived glyoxylate to glycine in situ. If this is the case, induction of mitochondrial SPT/AGT by glucagon would not significantly affect oxalate production from glycolate. To test this hypothesis, 100 mg (1.02 mmol) of Na-glycolate was administered orally to control rats and glucagon-treated rats, and the urinary excretion of oxalate and glycolate was measured.

Two-way analysis of variation showed that SPT activity was significantly affected by glucagon injection (P = 0.0001) but not by administration of glycolate (P = 0.8924). Urinary excretion of oxalate, glycolate, and glycine was significantly affected by administration of glycolate (P = 0.0001, 0.0001, and 0.0046, respectively) but not by glucagon injection (P = 0.2736, 0.5184, and 0.8339, respectively). No significant intragroups difference was detected in urinary excretion of serine, hydroxyproline, proline, ammonia, and urea.

As shown in Table 3, glycolate administration caused a marked increase (about eightfold) in oxalate excretion into urine; as expected, glucagon induction of mitochondrial SPT/AGT did not affect the glycolate-derived oxalate. A large amount of glycolate was also excreted into urine, and the mean recovery of administered glycolate in urine was about 43 to 46%, suggesting that a fairly large amount of administered glycolate had been metabolized through glyoxylate and glycine under the conditions used. In this case, no significant increase was observed in urinary excretion of ammonia and urea, consistent with the absence of amino group in administered glycolate (Table 2; Figure 2B).


    Discussion
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
In this study, we showed that urinary excretion of oxalate and glycolate was markedly increased when a large dose of L-hydroxyproline was administered to rats (Table 3), suggesting that glyoxylate formed from L-hydroxyproline in mitochondria can be oxidized to oxalate. A portion of glyoxylate oversupplied in mitochondria may leak out of mitochondria and serve as a substrate for lactate dehydrogenase (30) and glyoxylate reductase, resulting in the formation of oxalate and glycolate, respectively, and their excretion into the urine. We also observed that oxalate formation from L-hydroxyproline was significantly reduced when mitochondrial SPT/AGT had been induced by prior injection of glucagon. Glucagon did not affect other enzymes of hydroxyproline metabolism; we therefore think it likely that in glucagon-treated rats glyoxylate supplied from L-hydroxyproline in mitochondria is very efficiently metabolized to glycine in situ, reducing the harmful formation of oxalate.

Urinary excretion of glycine, serine, ammonia, and urea was also increased by L-hydroxyproline administration (Table 2). Especially, the increase in the excretion of ammonia plus urea accounted for as much as 43 to 45% of the administered dose of L-hydroxyproline not only in glucagon-treated rats but also in control rats, suggesting that hydroxyproline-derived glyoxylate was metabolized fairly rapidly via glycine, even in the absence of glucagon-induction of liver mitochondrial SPT/AGT. Nevertheless, the hydroxyproline-derived oxalate formation was distinctly less in glucagon-treated rats than in control rats. In this context, it is important that Km of SPT/AGT for glyoxylate is as low as 0.01 mM (31). It appears that a fairly high activity of such a low Km aminotransferase is necessary to maintain tissue concentration of glyoxylate sufficiently low, even after ingestion of a large amount of L-hydroxyproline. The increase in the excretion of glycine and serine was small, probably because they are physiologically important amino acids that are used in a variety of ways in cells, and their intracellular concentrations are maintained within a given range by serine hydroxymethyltransferase-catalyzed interconversion and their rapid metabolism by the mitochondrial glycine cleavage enzyme system, serine dehydratase, and SPT/AGT (7). In this study, we did not attempt to measure glyoxylate excretion, because in our previous study (at University of the Ryukyus) excretion of glyoxylate after administration of glycolate was as much as two orders of magnitude lower than that of oxalate (21), and measurement of total amount of glyoxylate excreted into urine was not simple enough due to the properties of glyoxylate to form adducts with various compounds (32).

The dose of L-hydroxyproline administered (630 mg) was about 5 times the amount that would be ingested if a rat had to supply daily heat production from total animal protein alone. For this calculation, heat production by a 170-g rat was assumed to be 17 kcal/d (33), and collagen content of total animal protein and hydroxyproline content of collagens were assumed to be 30% (wt/wt) and 10 to 13% (wt/wt) (4), respectively. Therefore, the experimental conditions applied to rats in this study were far from physiologic, but it is evident that oxalate can be formed from L-hydroxyproline in vivo, via its metabolism to glyoxylate in mitochondria.

We also observed that induction of mitochondrial SPT/AGT by glucagon had little effect on oxalate production from glycolate (Table 3). This finding is in accordance with our prediction and the report by Danpure et al. (34) that SPT/AGT misrouted to mitochondria in a group of patients with primary hyperoxaluria type 1 cannot fulfill its metabolic role of detoxicating glyoxylate properly.

Concerning the species-specific and food habit-dependent organelle distribution of SPT/AGT, it is important to recall that oxalate is an apparently useless and even toxic end-product of metabolism, because its insoluble calcium salt forms deposits in tissues, disrupting their functions. In patients with primary hyperoxaluria type 1, a hereditary oxalate stone disease caused by a functional deficiency of SPT/AGT (8), progressive renal deposition of calcium oxalate in the form of urolithiasis, and/or nephrocalcinosis leads to renal failure and systemic oxalosis, finally resulting in death, usually before the third decade of age (35,36 ). It is also important that glyoxylate is formed either from glycolate in peroxisomes or from L-hydroxyproline in mitochondria. In addition to its dual organelle distribution, SPT/AGT plays a dual role in glyoxylate metabolism and serine metabolism, although our recent studies showed that this enzyme contributed substantially to serine metabolism irrespective of mitochondrial or peroxisomal localization (7,37 ). Therefore, peroxisomal localization of SPT/AGT in herbivores and humans may be important for removal of glycolate-derived glyoxylate, because plants contain much more glycolate than animal tissues, although the content of glycolate in vegetables and fruits is not very high, at 1 to 7.5 mg/100 g wet weight (1), and glycolate is converted to glyoxylate in liver peroxisomes. Likewise, the present study suggests that mitochondrial presence of SPT/AGT in carnivores is important for the metabolism of glyoxylate formed from L-hydroxyproline in mitochondria, because animal proteins are rich in hydroxyproline as a constituent amino acid of collagens and elastins. This species-specific dual organelle localization of SPT/AGT is caused either by transcription of the SPT/AGT gene from two different start sites in exon 1 (16,38,39 ) or loss of the upstream translation initiation ATG codon as a result of mutations (40–42 ). It is attractive to hypothesize that those animal species that succeeded in providing SPT/AGT for the proper organelle as a result of gene mutations have been advantageous in surviving evolutionary selection. To investigate further the hypothesis, it would be highly desirable if rat peroxisomal SPT/AGT could be markedly and selectively induced; because no such means are available at present, we are going to undertake metabolic studies in rabbits and dogs.

Noguchi et al. (43) showed that mitochondrial extracts from the livers of dogs, cats, rats, and mice contained two forms of alanine:glyoxylate aminotransferase (AGT). The form-designated isozyme 1 is SPT/AGT or AGT-1, the subject enzyme of this study, and the other form-designated isozyme 2 (AGT-2) is a separate aminotransferase specific for L-alanine and glyoxylate. According to their results, the activity of AGT-2 in mitochondria of normal rat liver was much higher than the AGT activity of SPT/AGT, but administration of glucagon caused SPT/AGT activity to markedly exceed AGT-2 activity. In mitochondria from dog and cat livers, AGT activity of SPT/AGT exceeded that of AGT-2 activity, as in the case of glucagon-treated rats (43). In addition, the reported apparent Km of AGT-2 for glyoxylate (1.0 mM) (43) was much higher than that of SPT/AGT (0.01 mM) (31). We do not yet know how SPT/AGT and AGT-2 share the role of metabolizing glyoxylate in mitochondria, but SPT/AGT may be a more efficient catalyst due to its extremely low Km for glyoxylate.

In kidney mitochondria, glyoxylate is efficiently converted to L-serine via transamination to glycine, followed by further metabolism by mitochondrial glycine cleavage enzyme system and serine hydroxymethyltransferase (3). In the dog and cat, kidney mitochondria contain both SPT/AGT and AGT-2, SPT/AGT being predominant, whereas pig, rat, and monkey kidney mitochondria contain only AGT-2 (44). Thus, mitochondrial presence of SPT/AGT in carnivores may also be highly desirable for efficient metabolism in the kidney of hydroxyproline-derived glyoxylate to glycine, preventing oxidation to oxalate.


    Acknowledgments
 
This study was supported in part by a Grant-in-Aid for Encouragement of Young Scientists from the Ministry of Education, Culture, Sports, Science and Technology of Japan (to TT, #13770876). We thank Ms. Keiko Sato, Department of Biochemistry I, Hamamatsu University School of Medicine (HUSM), and Ms. Tomoko Maeda, Department of Urology, University of the Ryukyus, for technical assistance in the enzymatic determination of oxalate and for capillary electropheretic determination of oxalate and glycolate, respectively. We thank Dr. Masao Kanamori, Department of Public Health, HUSM, for advice on statistical analysis of data. We are also grateful to Dr. Masatoshi Kitagawa, Department of Biochemistry I, HUSM, Dr. Satoshi Yamaguchi, Department of Urology, Asahikawa Medical College, and Dr. Yusaku Okada, Department of Urology, Shiga University of Medical Science for their useful discussion.


    References
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 

  1. Harris KS, Richardson KE: Glycolate in the diet and its conversion to urinary oxalate in the rat. Invest Urol 18: 106–109, 1980[Medline]
  2. Maitra U, Dekker EE: Purification and properties of rat liver 2-keto-4-hydroxyglutarate aldolase. J Biol Chem 239: 1485–1491, 1964[Free Full Text]
  3. Lowry M, Hall DE, Brosnan JT: Hydroxyproline metabolism by the rat kidney: Distribution of renal enzymes of hydroxyproline catabolism and renal conversion of hydroxyproline to glycine and serine. Metabolism 34: 955–961, 1985[CrossRef][Medline]
  4. Neuman RE, Logan MA: The determination of hydroxyproline. J Biol Chem 184: 299–306, 1950[Free Full Text]
  5. Snell K: Enzymes of serine metabolism in normal, developing and neoplastic rat tissues. Adv Enzyme Regul 22: 325–400, 1984[CrossRef][Medline]
  6. Sallack HJ: Formation of serine from hydroxypyruvate and L-alanine. J Biol Chem 223: 1101–1108, 1956[Free Full Text]
  7. Xue HH, Sakaguchi T, Fujie M, Ogawa H, Ichiyama A: Flux of the L-serine metabolism in rabbit, human, and dog livers. Substantial contributions of both mitochondrial and peroxisomal serine:pyruvate/alanine:glyoxylate aminotransferase. J Biol Chem 274: 16028–16033, 1999[Abstract/Free Full Text]
  8. Danpure CJ, Jennings PR: Peroxisomal alanine:glyoxylate aminotransferase deficiency in primary hyperoxaluria type I. FEBS Lett 201: 20–24, 1986[CrossRef][Medline]
  9. Noguchi T: Amino acid metabolism in animal peroxisomes. In: Peroxisomes in Biology and Medicine, edited by Fahimi HD, Sies H, Berlin, Springer-Verlag, 1987, pp 234–243
  10. Noguchi T, Takada Y: Peroxysomal localization of serine: pyruvate aminotransferase in human liver. J Biol Chem 253: 7598–7600, 1978[Abstract/Free Full Text]
  11. Takada Y, Noguchi T: Subcellular distribution, and physical and immunological properties of hepatic alanine: glyoxylate aminotransferase isozymes in different mammalian species. Comp Biochem Physiol 72B: 597–604, 1982
  12. Danpure CJ, Guttridge KM, Fryer P, Jennings PR, Allsop T, Purdue PE: Subcellular distribution of hepatic alanine: glyoxylate aminotransferase in various mammalian species. Cell Sci 97: 669–678, 1990[Abstract/Free Full Text]
  13. Danpure CJ, Fryer P, Jennings PR, Allsop J, Griffiths S, Cunningham A: Evolution of alanine:glyoxylate aminotransferase 1 peroxisomal and mitochondrial targeting. A survey of its subcellular distribution in the livers of various representatives of the classes Mammalia. Aves and Amphibia. Eur J Cell Biol 64: 295–313, 1994[Medline]
  14. Oda T, Yanagisawa M, Ichiyama A: Induction of serine: Pyruvate aminotranferase in rat liver organelles by glucagon and a high-protein diet. J Biochem 91: 219–232, 1982[Abstract/Free Full Text]
  15. Uchida C, Funai T, Oda T, Ohhashi K, Ichiyama A: Regulation by glucagon of serine:pyruvate/alanine:glyoxylate aminotransferase gene expression in cultured rat hepatocytes. J Biol Chem 269: 8849–8856, 1994[Abstract/Free Full Text]
  16. Uchida C, Oda T, Sugiyama T, Otani S, Kitagawa M, Ichiyama A: The role of Sp1 and AP-2 in basal an protein kinase A-induced expression of mitochondrial serine:pyruvate aminotransferase in hepatocytes. J Biol Chem 277: 39082–39092, 2002[Abstract/Free Full Text]
  17. Strecker HJ: The interconvention of glutamic acid and proline. III. {Delta}1-pyrroline 5-carboxylate dehydrogenase. J Biol Chem 235: 3218–3223, 1960[Free Full Text]
  18. Fukushima M, Aihara Y, Ichiyama A: Immunochemical studies on induction of rat liver mitochondrial serine:pyruvate aminotransferase by glucagon. J Biol Chem 253: 1187–1194, 1978[Abstract/Free Full Text]
  19. Ishikawa K, Kaneko E, Ichiyama A: Pyridoxal 5'-phosphate binding of a recombinant rat serine:pyruvate/alanine:glyoxylate aminotranferase. J Biochem 119: 970–978, 1996[Abstract/Free Full Text]
  20. Carnie JA, Rowsell EV, Dabbaghian MK, Hobbs DR, Rowsell KV: Comparative and development studies on 4-hydroxy-2-oxoglutarate aldolase and hydroxyproline oxidase. Comp Biochem Physiol 71B: 681–688, 1982
  21. Ogawa Y, Miyazato T, Hatano T: Importance of oxalate precursors for oxalate metabolism in rats. J Am Soc Nephrol 10: S341–S344, 1999
  22. Ogawa Y, Hatano T: Urinary oxalate and citrate determination. Kidney and Dialysis Suppl 43: 151–157, 1997
  23. Ichiyama A, Nakai E, Funai T, Oda T, Katafuchi R: Spectrophotometric determination of oxalate in urine and plasma with oxalate oxidase. J Biochem 98: 1375–1385, 1985[Abstract/Free Full Text]
  24. Gutmann I, Bergmeyer HU: Urea. In: Methods of Enzymatic Analysis. 2nd ed., edited by Bergmeyer HU, New York and London-Weinheim, Verlag Chemie-Academic Press, 1974, pp 1791–1798
  25. Kun E, Kearney EB: Ammonia. In: Methods of Enzymatic Analysis. 2nd ed., edited by Bergmeyer HU, New York and London-Weinheim, Verlag Chemie-Academic Press, 1974, pp 1802–1806
  26. Mezl VA, Knox WE: Properties and analisis of a stable derivative of pyrroline-5-carboxylic acid for use in metabolic studies. Anal Biochem 74: 430–440, 1976[CrossRef][Medline]
  27. Kuttan R, Radhakrishnan AN: Biochemistry of the hydroxyprolines. In: Advances in Enzymology 37, edited by Meister A, New York, Interscience, 1973, pp 273–347
  28. Phang JM, Yeh GC, Scriver CR: Disorders of proline and hydroxyproline metabolism. In: The Metabolic and Molecular Bases of Inherited Disease, 7th Ed, edited by Scriver CR, Beaudet AL, Sly WS, Valle D, New York, McGraw-Hill, 1995, pp 1125–1146
  29. Horio Y, Tanaka T, Taketoshi M, Uno T, Wada H: Rat cytosolic aspartate aminotransferase: Regulation of its mRNA and contribution to gluconeogenesis. J Biochem 103: 805–808, 1988[Abstract/Free Full Text]
  30. Poore RE, Hurst CH, Assimos DG, Holmes RP: Pathways of hepatic oxalate synthesis and their regulation. Am J Physiol 272: C289–C294, 1997
  31. Yanagisawa M, Higashi S, Oda T, Ichiyama A: Properties and possible physiological role of rat liver serine:pyruvate aminotransferase. In: Biochemistry of Metabolic Processes, edited by Lennon DLF, Stratman FW, Zahlten RN, New York-Amsterdam-Oxford, Elsevier Biomedical, 1983, pp 413–426
  32. Funai T, Ichiyama A: High-performance liquid chromatographic determination of glyoxylate in rat liver. J Biochem 99: 579–589, 1986[Abstract/Free Full Text]
  33. McMahan T: Size and shape in biology: Elastic criteria impose limits on biological proportions, and consequently on metabolic rates. Science 179: 1201–1204, 1973[Abstract/Free Full Text]
  34. Danpure CJ, Cooper PJ, Wise PJ, Jennings PR: An enzyme trafficking defect in two patients with primary hyperoxaluria type 1: Peroxisomal alanine/glyoxylate aminotransferase rerouted to mitochondria. J Cell Biol 108: 1345–1352, 1989[Abstract/Free Full Text]
  35. Latta K, Brodehl J: Primary hyperoxaluria type I. Eur J Pediatr 149: 518–522, 1990[CrossRef][Medline]
  36. Danpure CJ, Purdue PE: Primary hyperoxaluria. In: The Metabolic and Molecular Bases of Inherited Disease. 7th Ed, edited by Scriver CR, Beaudet AL, Sly WS, Valle D, New York, McGraw-Hill, 1995, pp 2385–2424
  37. Xue HH, Fujie M, Sakaguchi T, Oda T, Ogawa H, Kneer NM, Lardy HA, Ichiyama A: Flux of the L-serine metabolism in rat liver. The predominant contribution of serine dehydratase. J Biol Chem 274: 16020–16027, 1999[Abstract/Free Full Text]
  38. Oda T, Funai T, Ichiyama A: Generation from a single gene of two mRNAs that encode the mitochondrial and peroxisomal serine:pyruvate aminotransferase of rat liver. J Biol Chem 265: 7513–7519, 1990[Abstract/Free Full Text]
  39. Sugiyama T, Uchida C, Oda T, Kitagawa M, Ichiyama A: Involvement of CCAAT/enhancer binding protein in regulation of the rat serine:pyruvate/alanine:glyoxylate aminotransferase gene expression. FEBS lett 508: 16–22, 2001[CrossRef][Medline]
  40. Takada Y, Kaneko N, Esumi H, Purdue PE, Danpure CJ: Human peroxisomal L-alanine: glyoxylate aminotransferase. Evolutionary loss of a mitochondrial targeting signal by point mutation of the initiation codon. Biochem J 268: 517–520, 1990[Medline]
  41. Purdue PE, Lumb MJ, Danpure CJ: Molecular evolution of alanine/glyoxylate aminotransferase 1 intracellular targeting. Analysis of the marmoset and rabbit genes. Eur J Biochem 207: 757–766, 1992[Medline]
  42. Lumb MJ, Purdue PE, Danpure CJ: Molecular evolution of alanine/glyoxylate aminotransferase 1 intracellular targeting. Analysis of the feline gene. Eur J Biochem 221: 53–62, 1994[Medline]
  43. Noguchi T, Okuno E, Takada Y, Minatogawa Y, Okai K, Kido R: Characteristics of hepatic alanine-glyoxylate aminotransferase in different mammalian species. Biochem J 169: 113–122, 1978[Medline]
  44. Takada Y, Noguchi T: Kidney alanine:glyoxylate aminotranferase isoenzymes; Species distribution, subcellular distribution and properties. Comp Biochem Physiol 65B: 133–138, 1980[CrossRef]
Received for publication January 2, 2002. Accepted for publication January 10, 2003.




This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
Q. Han, H. Robinson, Y. G. Gao, N. Vogelaar, S. R. Wilson, M. Rizzi, and J. Li
Crystal Structures of Aedes aegypti Alanine Glyoxylate Aminotransferase
J. Biol. Chem., December 1, 2006; 281(48): 37175 - 37182.
[Abstract] [Full Text] [PDF]


Home page
Mol Biol EvolHome page
G. M. Birdsey, J. Lewin, A. A. Cunningham, M. W. Bruford, and C. J. Danpure
Differential Enzyme Targeting As an Evolutionary Adaptation to Herbivory in Carnivora
Mol. Biol. Evol., April 1, 2004; 21(4): 632 - 646.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Takayama, T.
Right arrow Articles by Ogawa, Y.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Takayama, T.
Right arrow Articles by Ogawa, Y.


HOME CURRENT ISSUE ARCHIVES JASN Express ONLINE SUBMISSION AUTHOR INFO
EDITORIAL BOARD SUBSCRIBE FEEDBACK ALERTS HELP